Ares Genetics
Wholly owned subsidiary of Curetis GmbH, a developer of next-generation molecular diagnostic solutions for infectious diseases.
- B2B
- manufacturing
- commission
- health
- biotechnology
- medical devices
- artificial intelligence
- mobile app
- big data
- deep tech
- biotechnology
- horizon europe
- dt and ls
- core ai
- analytics
- ai applications
- testing
- eit ecosystem
- genetics and genomics
- dna
- medical testing
- drug development
- eit health
- nif defense security and resilience
- health it
- ai drug discovery
- tech for biotech and pharma
- medical diagnostics
- nif health crisis preparedness
- european health catapult (eit health)
- compbio
- nif biotech
- molecular biology
- ivd
- european health catapult 2019 (eit health)
Get premium to view all results
| Date | Investors | Amount | Round |
|---|---|---|---|
| - | investor | €0.0 | round |
| investor | €0.0 | round | |
N/A | Support Program | ||
| Total Funding | 000k | ||
Related Content
Analytics
Unlock the full power of analytics with a premium account
Track company size and historic growth
Track team composition and strength
Track website visits and app downloads
Tech stack
Tech stackLearn more about the technologies and tools that this company uses.